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only	 been	 exploited	 to	 a	 small	 extent.	 This	 creates	 a	 great	 potential	 for	 finding	 novel	
antibacterial	compounds	in	marine	fungi.		
	
In	 this	 study,	 the	 antibacterial	 and	 anticancer	 potential	 for	 five	 marine	 fungi	
Acremonium	 sp.	 TS7,	 Typhula	 sp.,	 Amylocarpus	 encephaloides,	 Pseudogymnoascus	 sp.	
TS12	and	Digitatispora	marina	have	been	 investigated	 for	antibacterial	and	anticancer	




sp.	 The	 active	 fractions	 were	 dereplicated	 with	 UPLC-QToF-MS.	 The	 antibacterial	
compounds	 were	 identified	 as	 rhamnolipids	 and	 were	 found	 in	 all	 active	 samples.	
Rhamnolipids	were	 also	 identified	 in	 the	 bacteria	 controls	with	 Leeuwenhoekiella	 sp.,	
suggesting	 that	Leeuwenhoekiella	 sp.	 is	 the	producer	 of	 rhamnolipids.	 	 The	bioactivity	
effects	 of	 our	OSMAC-approach	were	not	 as	 expected,	 this	 is	 probably	due	 to	 that	 the	
culture	 conditions	 selected	 for	 this	 study	 did	 not	 trigger	 the	 production	 of	 secondary	
metabolites.	 The	 full	 bioactivity	 potential	 for	 Acremonium	 sp.	 TS7,	 Typhula	 sp.,	
























































































































































Marine	 bioprospecting	 is	 the	 process	 of	 discovery	 and	 commercialization	 of	 new	
products	 based	 on	 marine	 organisms.	 The	 most	 explored	 resources	 in	 the	 marine	
environment	 include	 seafood,	 fish	 oil	 and	 food	 additives.	 There	 is	 a	 huge	 potential	 to	
increase	the	discovery	of	new	high-end	products,	such	as	pharmaceuticals.	The	oceans	
represent	 a	 highly	 competitive	 environment	 with	 a	 longer	 evolutionary	 history	 and	
greater	 less-exploited	 biodiversity,	 compared	 to	 the	 terrestrial	 habitat	 (Bolhuis	 &	
Cretoiu,	 2016).	 It	 can	 be	 assumed	 that	 the	 potential	 for	 discovery	 of	 new	 bioactive	
molecules	 in	 marine	 fungi	 could	 exceed	 that	 of	 fungi	 from	 other	 ecosystems	 (Silber,	
Kramer,	Labes,	&	Tasdemir,	2016).		
	
Compounds	 originating	 from	 living	 organisms	 can	 be	 called	 natural	 products.	 What	
these	natural	products	are	differs	greatly	and	includes	entire	organisms	(plant,	animal	
or	 a	 microorganism),	 parts	 of	 an	 organism	 (e.g.	 leafs	 or	 flowers),	 an	 extract	 of	 an	
organism,	 or	 pure	 compounds	 of	 microorganisms	 (Sarker	 &	 Nahar,	 2012b).	 In	 most	
cases	the	term	“natural	products”	refers	to	secondary	metabolites	produced	by	a	living	
organism.	Secondary	metabolites	molecules	that	are	not	strictly	necessary	for	survival,	
growth,	 development	 or	 reproduction	 for	 the	 organism	 that	 produces	 them	 (Martins,	
Vieira,	Gaspar,	&	Santos,	2014).	 In	 the	 field	of	marine	bioprospecting,	 there	have	over	
the	 years	 been	 developed	 strategies	 in	 order	 to	 isolate	 bioactive	 compounds	 as	
efficiently	as	possible.	Initial	approaches	were	primarily	focused	on	the	characterization	
of	 chemical	 compounds	 in	 natural	 products,	 before	 collecting	 bioactivity	 data.	 This	
strategy	 is	 labor-intensive,	 and	 may	 result	 in	 finding	 new	 chemistry,	 but	 with	 no	
guarantee	 for	 bioactive	 molecules.	 Today	 it	 is	 more	 common	 to	 use	 bioassay-guided	
isolation	strategy	and	to	only	isolate	bioactive	compounds.		
1.2	Marine	fungi	
Marine	 fungus	 is	 a	 group	of	 eukaryotic	 organisms	 in	 the	 kingdom	Fungi.	 They	 can	be	
divided	 in	 two	 major	 groups:	 unicellular	 (yeasts)	 and	 filamentous	 (molds)	 fungi.	
Filamentous	 fungi	grow	as	 tread-like	structures	called	hyphae.	Hyphae	can	be	 from	2-
10 µm	in	diameter	to	several	centimeters	and	the	structures	typically	grow	in	a	network	
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called	 mycelium	 (Madigan,	 Martinko,	 Stahl,	 &	 Clark,	 2012a).	 Marine	 fungus	 is	 an	
ecological	group	of	organisms	estimated	to	consist	of	1500	species,	excluding	those	that	
form	 lichens	 (Hyde	 et	 al.,	 1998).	 They	 inhabit	 most	 of	 the	 marine	 habitats	 and	 are	
distributed	 in	 tropical,	 temperate	and	Arctic	waters	 (Redou	et	al.,	2016).	Marine	 fungi	
can	grow	on	a	variety	of	substrata,	such	as	wood,	algae,	sediments,	corals	and	decaying	
leafs	of	mangroves	(Kohlmeyer	&	Kohlmeyer,	1979;	Redou	et	al.,	2016).	The	major	role	
of	 marine	 fungi	 in	 their	 ecosystem	 is	 to	 function	 as	 decomposers,	 the	 same	 role	
terrestrial	 fungi	 have	 in	 the	 terrestrial	 environment,	 but	 parasitic,	 pathogenic	 and	
symbiotic	fungi	occur	also	commonly.	Marine	fungi	are	one	of	the	main	decomposers	of	










estuarine	 habitat;	 facultative	 marine	 fungi	 are	 those	 from	 freshwater	 and	
terrestrial	 milieus	 able	 to	 grow	 and	 possibly	 also	 sporulate	 in	 the	 marine	
environment	(Kohlmeyer	&	Kohlmeyer,	1979,	p.	3).	
	
There	 are,	 from	 the	 definition	 from	 Kohlmeyer	 and	 Kohlmeyer	 (1979),	 two	 major	
groups	of	marine	 fungi:	obligate	and	facultative.	Facultative	marine	 fungi	are	 the	most	
studied	group	(Ebel,	2012).	The	obligate	marine	fungi	have	been	less	studied	(Sithranga	
Boopathy	&	Kathiresan,	2010)	and	have	very	few	reported	secondary	metabolites	(Ebel,	
2012).	 According	 to	 Jones	 et	 al.	 (2009),	 classification	 of	 marine	 fungi	 has	 become	
difficult	 and	 unclear,	 much	 due	 to	 the	 Kohlmeyers’	 definition.	 This	 definition,	 which	










development	 of	 antibiotic	 resistance	 (Bartlett,	 Gilbert,	 &	 Spellberg,	 2013).	 This	 has	
inevitably	 contributed	 to	 the	 evolution	 of	 resistant	 bacterial	 strains	 against	 most	 of	
antibiotic	 drugs	 on	 the	 market	 (Davies	 &	 Davies,	 2010).	 T	 carbapenem-resistant	
Enterobacteriaceae	(CRE)	Klebsiella	pneumonia	was	discovered	in	a	patient	in	2016	and	
was	 resistant	 against	 all	 antibacterial	 drugs	 on	 the	 market	 (Chen,	 Todd,	 Kiehlbauch,	
Walters,	 &	 Kallen,	 2017).	 With	 the	 rise	 of	 these	 multi-drug	 resistant	 pathogens,	 the	





years.	 Most	 of	 these	 organisms	 come	 from	 the	 terrestrial	 environment,	 so	 these	
microorganisms	represent	only	a	small	portion	of	the	microbial	diversity	(Imhoff,	2016).	
The	marine	ecosystems	are	less	explored,	even	though	marine	microorganisms	have	the	
potential	 to	produce	structurally	unique	bioactive	compounds	 that	cannot	be	 found	 in	
the	 terrestrial	 ecosystems	 (Bolhuis	 &	 Cretoiu,	 2016).	 The	 number	 of	 novel	 natural	
products	 isolated	 from	 marine-deprived	 fungi	 reached	 1100	 in	 2010	 (Rateb	 &	 Ebel,	
2011).	In	2002,	only	272	novel	natural	products	had	been	reported.	It	is	evident	that	the	
focus	on	marine-derived	fungi	has	increased	(Ebel,	2012),	however	the	majority	of	the	
sampled	 compounds	 are	 from	 fungal	 genera	 Penicillium	 and	Aspergillus	 (Silber	 et	 al.,	
2016).	 	 Even	 though	 marine	 fungi	 are	 starting	 to	 get	 more	 attention,	 they	 are	 still	







A	 pipeline	 is	 commonly	 used	 to	 describe	 the	 process	 of	
marine	 bioprospecting.	 It	 includes	 the	 main	 steps	 of	 the	
workflow	 from	 sample	 collection	 or	 marine	 organisms	 to	
structure	 elucidation	 and	 bioactivity	 profiling	 of	 pure	
compounds.	 The	 pipeline	 is	 constructed	 following	 a	
bioassay-guided	 purification	 strategy	 and	 is	 designed	 to	
identify	 novel	 bioactive	 compounds.	 At	Marbio,	 the	major	
steps	 in	 the	 pipeline	 include	 sample	 collection,	
fermentation,	 extraction,	 prefractionation,	 bioassays,	
dereplication,	compound	purification,	structure	elucidation	
and	 bioactivity	 profiling.	 The	 pipeline	 steps	 from	
fermentation	dereplication	are	 included	 in	 this	 study	 (Fig.	
1).	 Marbio	 applies	 High	 Throughput	 Screening	 (HTS),	 a	
process	 that	 analyzes	 many	 samples	 (crude	 extracts	 or	
fractions)	 in	 one	 set	 against	 a	 selected	 target	 (e.g.	
antibacterial	 and	 anticancer	 assays)(Carnero,	 2006).	 In	
order	to	have	a	successful	HTS,	a	platform	with	automated	




The	 cultivation	 of	microorganisms	 is	 important	 to	 be	 able	 to	 get	 enough	 biomass	 for	
every	 step	 in	 the	 bioprospecting	 pipeline.	 It	 is	 estimated	 that	 only	 0.1-1%	 of	marine	
microorganisms	 can	 be	 cultivated	 under	 laboratory	 conditions	 (Chai	 et	 al.,	 2012).	
Standard	 culturing	methods	 are	 limited	 and	 fail	 to	 activate	 every	metabolic	 pathway.	
Many	 biosynthetic	 gene	 clusters	 remain	 inactive	 or	 under-expressed	 in	 artificial	
laboratory	 culture	 conditions	 (Chiang,	 Lee,	 Sanchez,	 Keller,	 &	Wang,	 2009).	 Efforts	 to	
activate	these	silent	gene	clusters	and	trigger	production	of	unknown	compounds	have	
been	researched	by	adding	external	stimuli.	Modifications	of	culture	parameters,	such	as	








Addition	 of	 trace	 minerals	 and	 other	 micronutrients	 have	 shown	 to	 be	 effective	 for	
increased	growth	and	sporulation	(Vishniac	&	Santer,	1957).	This	approach,	which	uses	
modified	 traditional	 culture	 conditions,	 is	 commonly	 known	 as	 OSMAC	 (One	 Strain,	
Many	Compounds)	 (Bode	et	al.,	2002).	The	OSMAC-approach	 is	not	 the	only	approach	
that	 differs	 from	 the	 traditional	 methods.	 Modifying	 simple	 parameters	 (e.g.	
temperature,	 aeration	 and	 salinity)	 can	 trigger	 production	 of	 several	 unknown	
secondary	(Rateb	&	Ebel,	2011).	Mimicking	environmental	conditions	and	co-cultivation	
with	 other	 microorganisms	 has	 become	 a	 common	 approach	 to	 activate	 secondary	
metabolite	 production	 in	 microorganisms	 (Schroeckh	 et	 al.,	 2009).	 One	 of	 the	 major	
challenges	with	co-cultivation	with	slow-growing	marine	fungi	is	that	bacteria	can	take	
over	the	culture.	Another	problem	is	that	the	bacteria	itself	can	get	triggered	and	start	
producing	 bioactive	 secondary	 metabolites.	 A	 study	 found	 increased	 production	 of	




the	 cultivated	 organism.	 The	 target	 compounds	 can	 be	 extracellular	 compounds,	
intracellular	 proteins	 or	 both.	 The	 choice	 of	 extraction	 method	 depends	 heavily	 on	
target	compound	and	what	 the	source	material	 is	 (Sarker	&	Nahar,	2012b).	To	have	a	
successful	extraction,	several	parameters	have	to	be	considered.		The	first	parameter	is	
deciding	 what	 the	 target	 is.	 The	 target	 may	 be	 an	 unknown	 bioactive	 compound,	 a	




Solvents	 are	 necessary	 in	 most	 extraction	 methods	 to	 release	 target	 compounds	 and	
separate	 them.	 The	 three	 major	 groups	 of	 solvents	 used	 in	 extractions	 are	 polar,	
medium	 polar	 and	 nonpolar	 solvents.	 Fermentation	 media	 and	 other	 liquid	 culture	
media	contain	mainly	water,	which	is	a	polar	solvent.	Since	it	 is	vital	to	have	a	solvent	
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that	 is	 soluble	with	 the	 liquid	culture	media,	polar	solvents	are	 the	preferred	solvents	
for	the	extractions	of	the	fungi	fermentations	(Houssen	&	Jaspars,	2012).		
	
There	 are	many	 extraction	methods	 used	 for	 fungi	 (Houssen	 &	 Jaspars,	 2012;	Wiese,	
Ohlendorf,	Blümel,	Schmaljohann,	&	 Imhoff,	2011).	Two	of	 the	extraction	methods	are	
efficient,	 but	 have	 different	 focus	 points.	 Secondary	 metabolites	 are	 both	 found	
extracellular	 and	 intracellular.	 Different	 techniques	 can	 be	 applied	 depending	 on	
whether	 the	 focus	 is	 on	 extracellular	 secondary	 metabolites	 or	 both	 intra-	 and	
extracellular	 secondary	 metabolites.	 In	 the	 latter,	 extractions	 consists	 of	 three	 parts	
(Wu,	Oesker,	Wiese,	Schmaljohann,	&	Imhoff,	2014).	The	mycelium	is	separated	from	the	
fermentation	media	and	homogenized.	 	Ethanol	is	then	added	and	centrifuged,	and	the	
supernatant	 collected.	 The	 remaining	 aquatic	 phase	 and	 the	 fermentation	 media	 is	
extracted	with	EtAOc.	The	remaining	residue	from	the	aquatic	phase	and	fermentation	
media	is	extracted	with	methanol	(Wu	et	al.,	2014).	This	method	is	more	labor-intensive,	




directly	 to	 the	 liquid	 medium	 absorbing	 the	 produced	 and	 excreted	 secondary	
metabolites.	This	method	 removes	 inorganic	 salts,	which	 is	 abundant	 in	marine	 liquid	




Prefractionation	 of	 crude	 extracts	 reduces	 the	 complexity	 of	 crude	 extracts	 by	
separating	 the	 molecules	 after	 certain	 parameters.	 Prefractionation	 can	 increase	 the	
probability	of	 finding	activity	(Pham,	Toms,	Camp,	&	Quinn,	2015).	Chromatography	is	
usually	 used	 for	 this	 purpose	 and	 exploits	 how	 a	 compound	 distributes	 between	 the	
mobile	 phase	 and	 the	 solid	 phase.	 Compounds	 in	 the	 mixture	 interact	 with	 the	
stationary	phase	based	on	charge,	relative	solubility	or	adsorption.	The	retention	time	is	
the	time	a	compound	uses	to	travel	through	the	column	in	a	chromatographic	system.	A	
wide	 range	 of	 chromatographic	 separation	methods	 exists.	When	 choosing	 a	method,	
	 7	
the	 sample	 material	 that	 is	 to	 be	 fractionated	 and	 the	 desired	 outcome	 of	 the	
fractionation	 is	 taken	 into	 consideration.	 Chromatographic	 methods	 like	 liquid	




compounds.	 Depending	 on	 column	 material	 and	 solvents,	 it	 can	 be	 used	 to	 separate	
compounds	by	size,	polarity,	charge	or	affinity.	It	is	a	an	efficient	method	for	separating	
complex	mixture	of	compounds.	The	principle	of	flash	chromatography	is	the	same	as	in	








column	 material,	 solvent	 system	 and	 applications	 has	 to	 work	 for	 most	 compounds,	
making	 it	possible	 to	prefractionate	as	many	compounds	as	possible	at	a	 low	cost	and	
over	a	short	time	in	a	HTS	platform.			
1.8	Bioassays		
A	 bioassay	 is	 a	 standardized	 experiment	 that,	 in	 either	 an	 in	 vivo	 or	 in	 vitro	 system,	
determines	the	biological	activity	of	a	compound	in	a	sample.	There	are	two	groups	of	
bioassays:	 target-based	 and	 phenotypic	 assays.	 A	 target-based	 assay	 measures	 the	
compound’s	effect	on	a	specific	target	that	usually	is	a	protein	with	a	key	role	(Vasaikar,	
Bhatia,	 Bhatia,	 &	 Chu	 Yaiw,	 2016).	 The	 phenotypic	 assay	 is	 used	 to	 detect	 an	 activity	
using	of	cells,	tissue	or	whole	organisms	in	a	sample.	Knowledge	of	potential	targets	is	
not	needed	(Swinney,	2013).	The	main	purpose	with	phenotypic	assay	is	to	discover	a	















MIC	 is	 used	 to	 determine	 the	 lowest	 concentration	 of	 different	 antibacterial	 agents	
exerting	bacteriosidal	or	bacteriostatic	effect	against	the	exposed	bacteria.	With	regards	
to	 antibacterial	 drug	 discovery,	 these	 agents	 can	 be	 crude	 extracts,	 fractions,	 purified	
natural	 products	 or	 synthetically	 produced	 compounds.	 If	 an	 antibacterial	 agent	 does	
not	inhibit	or	halt	bacterial	growth,	the	bacteria	will	grow	and	cloud	the	growth	media.	
Inhibition	 of	 bacterial	 growth	 by	 the	 tested	 agents	will	 on	 the	 other	 hand	 result	 in	 a	
clear	assay	well.	MIC	is	a	visible	assay,	were	growth	and	clouding	of	the	growth	media	
differs	from	wells	without	growth.	In	addition	to	visual	well	inspection	to	detect	activity,	









applied	 to	 find	 anticancer	 activity	 in	 crude	 extracts	 and	 fractionated	 samples.	 The	
Promega	CellTiter	96®	Aqueous	One	solution	Cell	Proliferation	Assay	is	a	colorimetric	




tetrazolium,	 inner	 salt;	 short	MTS]	 is	 added	 at	 the	 end	of	 the	 incubation	 time	 to	 each	
well.	The	tetrazolium	salt	enters	the	cytocol	and	is	reduced	to	a	purple	end	product	by	
the	mitochondrion	 in	metabolically	 active	 cells.	 The	 formazan	product	 is	 soluble	 over	
the	cell	membrane.	The	reduction	of	MTS	to	formazan	will	only	take	place	in	living	cells,	
whereas	 dead	 cells	 will	 not	 reduce	 MTS.	 The	 number	 of	 living	 cells	 is	 directly	
proportional	with	 the	 level	 of	 formazan	product	 produced.	 The	 color	 concentration	 is	
measured	 spectrophotometric	 at	 490	 nm	 (Promega,	 2012).	 Negative	 and	 positive	
controls	are	used	to	calculate	percent	survival.	
1.9	Dereplication	
Dereplication	 is	 a	 process	 used	 in	 screening	 for	 natural	 products	 with	 bioactivity	
screening,	 mass	 spectrometric	 techniques	 and	 mass	 spectrometric	 databases	
(Gaudencio	&	Pereira,	2015).	It	is	a	rapid	process	that	is	a	key	element	in	the	discovery	
of	 novel	 natural	 products	 (Nielsen,	 Månsson,	 Rank,	 Frisvad,	 &	 Larsen,	 2011).	
Compounds	in	active	crude	extracts	or	fractions	are	identified	with	molecular	mass	and	
calculated	 molecular	 formula	 with	 mass	 spectrometry.	 The	 analyses	 distinguish	
previously	reported	bioactive	secondary	compounds,	from	those	that	contain	secondary	
metabolites	with	novel	chemistry	and/or	novel	bioactivity.	Isolation	of	compounds	is	a	
labor-intensive	 task,	 thus	dereplication	 is	done	 to	eliminate	known	compounds	before	
an	isolation	process	is	initiated	(Sarker	&	Nahar,	2012a).	
1.9.1	UPLC-QToF-MS	
The	bioactive	 samples	 are	 analyzed	 in	 this	 study	 for	with	UPLC-QToF-MS.	However,	 a	
wide	 range	 of	 options	 exist	 when	 it	 comes	 to	 inlet	 systems,	 isolation	 techniques	 and	
mass	 filters	 (Lampman,	 Pavia,	 Kriz,	 &	 Vyvyan,	 2010;	 Sarker	 &	 Nahar,	 2012a).	 The	
components	 in	 Marbio’s	 mass	 spectrometry	 system	 include	 Ultra	 Pressure	 Liquid	





sprayed	 out	 in	 a	 fine	 aerosol	 with	 the	 help	 of	 nitrogen	 gas.	 Exposure	 to	 a	 very	 high	
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voltage	 electrically	 charges	 the	 droplets	 that	 rapidly	 shrink	 in	 size	 as	 mobile	 phase	
molecules	evaporate	 from	their	 surface,	which	 ionizes	 the	compounds.	This	method	 is	
commonly	known	as	electrospray	ionization	(ESI)	and	can	be	performed	in	positive	(ESI	
+)	 or	 negative	 (ESI-)	mode	 (Lampman	 et	 al.,	 2010).	 The	Quadople	 and	 Time-of-Flight	
(ToF)	are	both	mass	analyzers.	They	work	together	to	separate	the	ionized	compounds	






















































Five	marine	 fungi	 isolates	were	selected	 for	cultivation	 (Table	1-2).	These	 five	marine	
fungi	were	fermented	based	on	the	OSMAC-approach	on	four	different	media	and	at	two	
different	 temperatures.	 Half	 of	 the	 fermentations	 were	 co-cultivated	 with	 the	marine	





10℃	and	 100	 rpm	 shaking,	 while	 60	 other	 fermentations	 were	 incubated	 at	 15℃.	 The	 10℃	and	 15℃	
fermentations	were	 split	 in	 half,	 were	 30	 fermentations	were	 co-cultivated	 (CO)	 and	 30	 fermentations	
were	monocultivated	 (MO).	 This	 resulted	 in	 120	 crude	 extracts	 that	 were	 tested	 for	 antibacterial	 and	
anticancer	activity.		
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Three	of	 the	species	belonged	 to	 the	 fungal	phylum	Ascomycota	(Acremonium	sp.	TS7,	
Amylocarpus	encephaloides	and	Pseudogymnoascus	sp.	TS12).	The	 last	 two	belonged	 to	
the	Basidiomycota	phylum	 (Typhula	sp.	 and	Digitatispora	marina).	These	 strains	were	
sampled	 from	different	 parts	 of	 the	Atlantic	Ocean	 from	deep-sea	 sponges,	wood	 and	
algae	 (Table	2).	The	wood	and	 seaweed-associated	 fungal	 species	 are	obligate	marine	
fungi,	 whereas	 the	 ecology	 of	 the	 sponge-associated	 strains	 remains	 unsolved.	 These	
five	marine	 fungi	have	not	been	 investigated	 for	bioactive	 secondary	metabolites.	The	
human	pathogenic	 bacteria	 used	 in	 antibacterial	 assay	 are	S.	aureus	 (ATCC	25923),	E.	
coli	 (ATCC	 25922),	 E.	 faecalis	 (ATCC	 29212),	 P.	 aeruginosa	 (ATCC	 27853)	 and	 S.	
















































































10	 g/L	 EDTA,	 4.4	 g/L	 ZnSO4*	
7H2O,	 1.01	 g/L	 MnCl2*4H2O,	
0.32	 g/L	 CoCl2*6H2O,	 0.315	
g/L	 CuSO4*	 5H2O,	 22	 g/L	
(NH4)6Mo7O24*4H2O,	 1.47	 g/L	

















Wood	Medium	(WM)	 10	 g/L	 grinded	 wood	 chips,	





2	 g/L	 Corn	 Flour	 (Risenta®),	







































Chemical		 Supplier	 Distributor		 Product	number	
Acetone	 Sigma	Aldrich	 MO,	USA	 	
DMSO	 Sigma	Aldrich	 MO,	USA	 W387520	
EDTA	 Sigma	Aldrich		 MO,	USA		 E6758-100G	
ZnSO4*7H2O	 Sigma	Aldrich		 MO,	USA	 24750-100G	
MnCl2*4H2O	 Sigma	Aldrich		 MO,	USA		 221279-100G	
CoCl2*6H2O	 Sigma	Aldrich		 MO,	USA	 C8661-25G	
CuSO4*5H2O	 Sigma	Aldrich		 MO,	USA		 209198-100G	
(NH4)6Mo7O24*4H2O	 Sigma	Aldrich		 MO,	USA	 09878	
CaCl2*2H2O	 Sigma	Aldrich		 MO,	USA	 C3881	
FeSO4*7H2O	 Sigma	Aldrich		 MO,	USA		 215422	
NaNO3	 Sigma	Aldrich		 MO,	USA	 S5506	
KH2PO4	 Merck	KGaA	 Germany	 1.04871.	
KCl	 Merck	KGaA	 Germany	 1.04935.5000	
MgSO4*7H2O	 Sigma	Aldrich		 MO,	USA		 63138-250G	
NaCl	 Sigma	Aldrich		 MO,	USA		 S5886	
Na2HPO4*2H2O	 Sigma	Aldrich		 MO,	USA		 30412	
Diaion®	HP-20	(Supelco)	 Sigma	Aldrich		 MO,	USA		 13607	
Diaion®	HP-20SS	 Sigma	Aldrich		 MO,	USA		 13613-U	


























	 	 	 	














RPMI-1640	 Merck	KGaA	 Germany	 FG	1383	





















Formic	acid	99%	UMC-MS	 BioSolve	BV	 Nederland		 069141	






D-Mannitol	 Sigma	Aldrich		 MO,	USA		 63560	
Peptone	from	casein	 Sigma	Aldrich		 MO,	USA		 82303	
Corn	Meal	Agar	 Sigma	Aldrich	 MO,	USA	 42347	
Agar-agar	 Sigma	Aldrich	 MO,	USA	 A1296-1KG	
Majsmjöl	 Risenta	AB	 Sweden	 	







The	 isolated	marine	 fungi	were	 either	 kept	 in	 a	 glycerol	 solution	 in	 -80℃	or	 on	 agar	
plates	 at	 10℃.	 The	 marine	 fungi	 were	 subcultivatied	 to	 grow	 enough	 biomass	 for	
fermentation.	 The	 cryopreserved	 fungi	 isolates	were	 taken	 out	 of	 the	 -80	 freezer	 and	
subcultivated	on	0.2	ASMEA	and	ASCMA	plates	and	grew	3-4	weeks.		The	subcultivated	





The	 marine	 fungi	 were	 fermented	 as	 monoculture	 or	 co-culture	 with	 four	 different	
media,	with	10℃	and	15℃	incubation	(Fig.1).	The	fermentation	media	were	constructed	
with	 a	 carbon	 source,	 artificial	 seawater,	 two	 times	minimal	medium,	 Vishniac	 Spore	
solution	(a	trace	metal	solution)	and	MQ-H2O	(Table	3).	The	Vishniac	Spore	Solution	was	
made	 accordingly	 to	 Vishniac	 and	 Santer	 (1957).	 Four	 different	 carbon	 sources	were	
selected,	 giving	 a	 total	 of	 four	 different	 liquid	 fermentation	 media.	 The	 dried	
Ascophyllum	nodosum	and	 the	wood	 chips	were	 pulverized	with	 IKA®	A11	 basic	 (IKA	
Werke	GmbH	&	Co.	KG,	Germany)	before	they	were	added	to	the	medium.	The	seaweed	
medium	 (SM),	 the	 wood	 medium	 (WM),	 the	 corn	 flour	 medium	 (CFM)	 and	 the	 malt	
extract	medium	(MEM)	were	made	according	to	table	3.	They	were	autoclaved	at	121℃	
for	 60	minutes	with	 absorbent	 cotton	 (Macdonald	 &	 Taylor	 Limited,	 UK)	 in	 the	 flask	
opening	 and	 covered	 with	 commercial	 aluminum	 foil.	 For	 each	 fungus,	 1.5	 L	 of	 each	
fermentation	 medium	 1.5	 L	 was	 made,	 of	 which	 0.250	 L	 liquid	 media	 was	 used	 per	




cultivation	 treatment	 with	 a	 marine	
bacterium	 and	 two	 media	 controls	 (were	
one	had	 co-cultivation)	were	used	 (Fig.	 3).	
These	 were	 divided	 in	 two	 treatments,	








To	 simplify	 the	 notation	 of	 the	 different	 media	 and	 treatments	 of	 each	 flask,	 a	 note	
system	 was	 created.	 The	 marine	 fungi	 species	 were	 annotated	 with	 fermentation	
number	(Table	1)	and	parameter	codes	(Table	5).	For	example:	species	Acremonium	sp.	
Figure	3:		Shows	setup	of	fermentation	per	media	used.	
MO	 =	monoculture,	 CO-C	 =	 co-cultivation,	 MC=	media	
control	 and	 MC	 +CO-C	 =	 bacteria	 control.	 The	 blue	
flasks	are	incubated	at	10℃	with	100	rpm	shaking	and	














Figure	4:	Shows	an	example	of	 the	notation	 for	 the	 fermentation	 ID	of	Acremonium	sp.	TS7	 fermented	with	
MEM,	 co-cultivation	 and	 incubation	 at	 10℃	and	 100	 rpm	 shaking.	 It	 is	 based	 on	 cultivation	 method	 (co-














The	 60	 co-cultivated	 fermentations	 were	 inoculated	 at	 least	 two	 weeks	 before	
extraction.	The	bacteria	Leeuwenhoekiella	sp.	(strain	M09W024)	was	kept	on	agar	plate	




mL	M19	medium.	 The	 Erlenmeyer	 flask	was	 incubated	 at	 10℃ with	 100-150	 rpm	 for	
	 20	
three	days,	until	growth	was	visible.	The	60	co-culturing	fermentations	were	inoculated	
by	 adding	 2.5	 mL	 of	 the	 bacteria	 solution	 to	 each	 fermentation	 of	 marine	 fungi.	 The	
inoculation	was	done	under	sterile	conditions	(Class	II	hood)	to	prevent	contamination.	




Before	extraction	 samples	 from	 the	 fermentations	were	 taken	out	 in	order	 to	 conduct	
DNA	analysis	to	identify	possible	contaminates.	From	each	fermentation,	400	µL	sample	
was	 transferred	 over	 to	 a	 eppedorftube.	 The	 sampling	 was	 conducted	 for	 all	 120	
fermentations	 to	 identify	 possible	 fungal	 contaminations	 in	 the	 fermentations.	 The	
samples	were	stored	at	-20℃	until	they	were	used.				
	
The	 internal	 transcribed	 spacer	 (ITS)	 regions	 4	 and	 5	 were	 used	 to	 identify	 fungal	
contamination	(Schoch	et	al.,	2012).	To	identify	contaminants	from	other	fungal	species,	














The	 PCR	 products	 were	 determined	 by	 gel	 electrophoresis.	 The	 1%	 agarose	 gel	 was	
made	by	melting	1	g	agarose	 in	100	mL	1xTBE	Buffer.	The	 solution	was	 cooled	down	
before	2.5	µL	100x	gel	red	was	added.	The	solution	was	added	to	OwlTM	EasyCastTM	B2	





When	 the	 PCR	 products	 had	 been	 confirmed	with	 the	 correct	 size,	 the	 PCR	 products	




The	 master	 mix	 for	 PCR	 sequencing	 was	 made	 with	 2	µL 	template	 (purified	 PCR	
product),	2	µL	BigDye	3.1,	2 µL	5x	sequencing	buffer,	1	µL	ITS4	(or	ITS5)	primer	(1 µM)	














antibacterial	 and	 anticancer	 activity.	 To	 extract	 the	 produced	 secondary	 metabolites	
from	the	fermentationse,	the	Resin	Diaon®	HP-20	was	used.	This	has	a	high	affinity	for	










of	 the	 fermentations.	 The	 fermentations	 were	 incubated	 at	 the	 initial	 fermentation	
conditions	for	two	days	before	they	were	extracted.		
2.6.3	Extraction	of	metabolites	in	the	fermentation	media	
The	metabolites	 secreted	 in	 the	 fermentation	media	were	 extracted	 after	 two	days	 of	
incubation.	 The	 fermentation	 medium	 was	 first	 separated	 by	 using	 cheesecloths	
(Osteklede,	 finmasket,	 Dansk	 hjemmeproduktion,	 Denmark),	 1L	 filter	 flask	 and	 a	
Buchner	 funnel	 with	 vacuum	 filtration.	 The	 cheesecloth	 restrained	 the	 resin,	 mycelia	
and	other	large	particles	from	escaping	with	the	water	phase.	The	resin	and	cheesecloth	
were	 washed	 with	 200	 mL	 MQ-H2O	 and	 transferred	 back	 to	 the	 fermentation	 flask	
without	 losing	 the	 contents	 on	 the	 filter.	 Then	 100	 mL	 methanol	 was	 added	 and	
incubated	 for	 1-1.5	 hours.	 The	 water	 phase	 collected	 was	 discarded.	 After	 the	
incubation,	 the	 methanol	 was	 poured	 gently	 over	 a	 Whatman	 grade	 3	 90	 mm	 filter	
(Sigma	Aldrich,	MO,	USA)	connected	to	a	new	Buchner	funnel	and	filtration	flask	under	
vacuum.	 The	 resin	 was	 kept	 in	 the	 bottle	 during	 the	 first	 filtration.	 The	 filter	 was	
discarded	and	100	mL	methanol	was	 added	 to	 the	bottle	 for	 a	 second	extraction.	The	
flask	was	incubated	for	at	least	30	minutes	and	was	then	filtrated	with	a	new	Whatman	
grade	3	90mm	filter	(Sigma	Aldrich,	MO,	USA).	The	methanol	phases	were	combined	and	
transferred	over	 to	 a	100	mL	 round	bottom	 flask	 and	dried	under	 vacuum	 (Laborota,	
Heidolph	 Instruments	GmbH	and	Co,	Germany).	 This	 extraction	method	was	 repeated	










bioactivity	 screening.	 The	 crude	 extracts	 were	 taken	 out	 of	 storage	 and	 thawed	
completely	 in	 room	 temperature.	 Stock	 plates	 for	 bioactivity	 testing	 were	 made	 by	
	 23	
transferring	250	µg	 crude	 extracts	 into	deep	well	 plates.	 The	plates	were	 frozen	 solid	
and	 freeze-dried	 (Heto	 Powerdry	 PL9000,	 Thermo	 Fisher	 Scientific,	 MA,	 USA).	 The	
freeze-drying	 process	 took	 approximately	 three	 days.	 The	 freeze-dried	 crude	 extracts	

















The	 five	 overnight	 cultures	were	 taken	 out	 of	 the	 incubator	 and	2	mL	of	 the	 bacteria	














Bacteria	strain	 Growth	media	 Incubation	time	 Bacterial	density	
S.	aureus		 MH-broth	 2.5	hours	 0,5-3*105	CFU1	(2500-15000	
CFU/well)	
E.	coli	 MH-broth	 1.5	hours	 0,5-3*105	CFU1	(2500-15000	
CFU/well)	
E.	faecalis		 BHI-broth	 1.5	hours	 0,5-3*105	CFU1	(2500-15000	
CFU/well)	
P.aeruginosa	 MH-broth	 2.5	hours	 3-7*104	CFU1	(1500-3500	
CFU/well)	









	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
A	 N	 1	 1	 9	 9	 17	 17	 25	 25	 33	 33	 P	
B	 N	 2	 2	 10	 10	 18	 18	 26	 26	 34	 34	 P	
C	 N	 3	 3	 11	 11	 19	 19	 27	 27	 35	 35	 P	
D	 N	 4	 4	 12	 12	 20	 20	 28	 28	 36	 36	 P	
E	 N	 5	 5	 13	 13	 21	 21	 29	 29	 37	 37	 P	
F	 N	 6	 6	 14	 14	 22	 22	 30	 30	 38	 38	 P	
G	 N	 7	 7	 15	 15	 23	 23	 31	 31	 39	 39	 P	
















On	 the	 forth	 day	 of	 the	 antibacterial	 screening,	 the	 microtiter	 plates	 were	 visually	
inspected	for	inhibition.	The	photometric	instrument	1420	Multilabel	Counter	VICTOR3	
TM	 (PerkinElmer,	 MA,	 USA)	 was	 used	 to	 measure	 OD.	 Cut-off	 values	 have	 been	
established	as	guidelines	to	define	the	antibacterial	activity	the	sample	has	with	OD600	
values.		
Active <  0.05 
Questionable 0.05 –  0.09 
Inactive >  0.09 	
		




The	 120	 redissoved	 crude	 extracts	 were	 tested	 for	 anticancer	 activity	 against	 the	
adherent	A2058	melanoma	cancer	cell	line.	The	A2058	were	detached	from	the	growth	
flask	with	PBS-wash	 and	 trypsin	 treatment,	 and	 added	 to	microtiter	plates	with	2000	
cells/well.	 The	 plates	 were	 incubated	 for	 24	 hours	 at	 37℃	and	 5%	 CO2	 (Panasonic	
Biomedical,	 Japan)	 to	 allow	 the	 cells	 to	 attach.	 The	 crude	 extract	 test	 solutions	 were	
prepared	 by	 adding	 crude	 extracts	 from	 stock	 plate	 and	RPMI-1640	 cell	medium	 in	 a	
new	deep	well	plate	with	50	µg/ml	test	concentration.	The	incubated	microtiter	plates	
were	 inspected	microscopically	 to	 check	 for	 good	 growth	 of	 the	 cancer	 cells.	 The	 cell	
media	were	then	removed	from	each	well	with	a	multichannel	pipette	and	100 µl	crude	
extracts	 test	 solutions	 and	 cell	medium	were	 added	 to	 the	wells.	 Two	 parallels	 were	
used.	Cancer	cells	with	cell	medium	were	used	as	negative	controls	and	positive	control	
was	cell	media	and	0.5%	Triton.	Triton	and	A2058	cancer	cells	were	tested	vigorously	







	 1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	
A	 	 	 	 	 	 	 	 	 	 	 	 	
B	 	 1	 1	 7	 7	 13	 13	 19	 19	 Neg	 	 	
C	 	 2	 2	 8	 8	 14	 14	 20	 20	 Neg	 	 	
D	 	 3	 3	 9	 9	 15	 15	 21	 21	 Neg	 	 	
E	 	 4	 4	 10	 10	 16	 16	 22	 22	 	 	 	
F	 	 5	 5	 11	 11	 17	 17	 23	 23	 	 	 	
G	 	 6	 6	 12	 12	 18	 18	 24	 24	 	 	 	
H	 	 	 	 	 	 	 	 	 	 	 	 	
	
After	the	72	hour	incubating,	10 µL	CellTiter	96®	Aqueous	One	Solution	were	added	to	
wells.	 The	 microtiter	 plates	 were	 incubated	 for	 1	 –1.5	 hours	 at	 37℃	and	 5%	 CO2	
(Panasonic	 Healthcare,	 Osaka,	 Japan).	 The	 absorbance	was	measured	 at	 485	 nm	with	




1       
(average parallels− average postive controll )




Active <  50 % cell survival 
Questionable = 50− 60 % cell survival 






There	was	not	 found	any	anticancer	or	anticancer	activity	 in	 the	bioactivity	screening,	
therefore	 were	 eight	 crude	 extracts	 selected	 for	 prefractionation	 based	 the	 crude	
extracts	yields.	One	monoculture	and	one	co-cultivated	crude	extracts	were	selected	per	






to	 100	mL	 round	 bottom	 flasks	 and	 dried	 under	 vacuum	with	 a	 rotavapor	 (Laborota,	
Instruments	GmbH	and	Co,	Germany).	The	dried	solutions	were	then	resolved	in	8	mL	
90%	methanol	 and	 2	 g	Diaion®	HPSS-20	was	 added	 to	 each	 sample.	 The	 dried	 under	
vacuum	with	rotavapor	until	 it	was	completely	dry.	The	dry	crude	extract	and	column	
material	 was	 added	 on	 top	 of	 the	 flash	 column	 (Biotage®	 SNAP	 Cartridge	 KP-Sil	 10g,	




75:25	 and	 100:0)	 followed	 by	 methanol:acetone	 to	 acetone	 in	 two	 steps	 (50:50	 and	
0:100).	The	fractionations	were	done	in	a	two-step	flash	chromatography	program.	The	
first	 step	 fractionated	 and	 eluted	 the	 crude	 extract	 with	 an	 increasing	 gradient	 of	













The	 fractions	 were	 taken	 out	 of	 storage	 freezer	 and	 thawed	 completely	 in	 room	
temperature.	 A	 stock	 plate	 for	 bioactivity	 testing	 was	 made	 by	 transferring	 500	µg	
fractions	 in	 a	 deep	 well	 plate.	 The	 plate	 was	 frozen	 solid	 and	 freeze-dried	 (Heto	
Powerdry	PL9000,	Thermo	Fisher	Scientific,	MA,	USA).	The	freeze-drying	process	took	














The	 five	active	or	questionable	 fractions	 from	 the	antibacterial	 screening	 (2.9.2)	were	
retested	 to	 find	 minimal	 inhibition	 concentration	 (MIC).	 The	 same	 procedure	 for	
antibacterial	 screening	 for	 crude	extracts	 (2.9.1)	were	used.	Test	 concentrations	were	
50	µg/mL,	 25	µg/mL,	 12.5	µg/mL,	 6.25	µg/mL	 and	 3.125	µg/mL.	 The	 retest	 was	
conducted	 two	 times.	 In	 the	 first	 retest,	 none	 of	 the	 five	 fractions	 were	 active.	 To	
investigate	if	this	was	a	solubility	issue,	a	new	deep	well	plate	was	made	with	the	active	
fractions	from	the	antibacterial	screening.	The	plate	was	freeze-dried	and	dissolved	with	





The	 five	active	 fractions	were	 investigated	with	UPLC-QToF-MS.	The	 inactive	 fractions	
X701A.2-5,	 X702D.2-5	 and	X705B.2-5	were	 also	 included	 in	 the	 analysis	 to	 be	 able	 to	
identify	peaks	that	were	responsible	for	the	bioactivity.	The	samples	were	analyzed	on	a	
Vion®	 IMS	 QToF	 with	 a	 C18	 1.7µM	reverse	 column	 in	 the	 ESI+	 mode	 (Table	 9).	 The	
samples	were	prepared	by	adding	10	µL	sample	in	a	vial	with	90	µL	90%	methanol.	The	















Time	(min)	 Flow	rate	(mL/min)	 Solvent	A	gradient	(%)	 Solvent	B	gradient	(%)	
0.00	 0.450	 90.0	 10.0	
12.00	 0.450	 0.0	 100.0	


















Four	 bacteria	 controls	 containing	 only	 medium	 and	 Leeuwenhoekiella	 sp	 were	
investigated	with	UPLC-QToF-MS	to	be	able	to	identify	possible	production	of	bioactive	





















A	 selection	 of	 DNA	 samples	 from	 the	 fermentations	 was	 used	 to	 check	 for	 fungal	
contamination.	The	ITS4	and	ITS5	primer	sequences	were	used	to	amplify	the	ITS	region	
in	 the	 DNA	 samples.	 The	 amplified	 PCR	 products	 were	 sequenced	 and	 generated	
sequences	were	used	in	BLAST	searches	against	the	National	Center	for	Biotechnology	
Information’s	nucleotide	database.	Comparison	of	BLAST	hits	with	initial	strain	identity	
showed	 contamination	 in	 the	Pseudogumnoacus	sp.	 TS12	 (704).	 The	 contaminant	was	






isolates	 (Fig.	 5).	 The	 fermentations	 did	 not	 get	 extracted	 at	 the	 same	 day,	 so	 the	























The	 fermentations	 with	 10℃	incubation	 and	 100	 rpm	 shaking	 had	 generally	 lower	
yields	 compared	 to	 fermentations	 with	 15℃	incubation	 without	 shaking	 (Fig.	 6).	 The	
trend	is	evident	on	isolate	 level	as	well.	All	 four	 isolates	had	significantly	higher	crude	





Figure	 7:	 Boxplot	 of	 all	 crude	 extracts	 from	 each	 isolate	 separated	 after	 the	 incubation	






the	 particles	 in	 the	 media	 did	 end	 up	 in	 the	 extracts	 in	 some	 degree,	 thus	 can	 have	
increased	 the	 yield	 in	 total.	 MEM	 was	 the	 only	 media	 that	 was	 homogeneous.	 The	




With	96	 fermentations	 in	 this	study,	 that	would	have	been	an	enormous	 task.	 Instead,	
the	 crude	 extracts	 were	 tested	 for	 antibacterial	 –and	 anticancer	 activities	 to	 identify	
crude	 extracts	 with	 bioactivity.	 The	 active	 crude	 extracts	 would	 subsequently	 be	
prefractonated.	This	would	save	time	and	labor	by	removing	inactive	samples.		
	







coli,	 S.	 agalactiae,	 P.	 aeruginosa,	 S.	 aureus	 or	 E.	 faecalis	 at	 50  and 100 µg/ml	 test	










and	 X705A.2	 (Table	 12).	 	 All	 these	 extracts	 gave	 cell	 survival	 between	 72-75	 %	 at	



















Figure	10:	 The	 figure	 shows	 results	 from	 the	 anticancer	 screening	 of	 the	 14	 different	 extracts,	 two	
from	 isolate	 701,	 four	 extracts	 from	 each	 of	 the	 three	 isolates	 702,	 703	 and	 705.	 The	 screening	
concentration	 was	 50	𝛍g/ml.	 The	 crude	 extracts	 from	 705	 (D.	 marina)	 were	 the	 only	 isolate	 that	




Due	 to	 the	 lack	 of	 hits	 from	 the	 bioassays	 done	 on	 the	 crude	 extracts,	 several	
fermentations	 were	 selected	 for	 prefractionation	 based	 on	 other	 criteria.	 Pairs	 of	
monoculture	 –	 and	 co-culture	 fermentation	 from	 the	 four	 different	 isolates	 were	
selected.	 The	 pairs	 had	 the	 same	 fermentation	 medium.	 The	 following	 samples	 were	
prefractionated:	X701A.2,		
XY701A.2,	X702D.2,	XY702D.2,	X703C.2,	XY703C.2,	X705B.2	and	XY705B.2.	These	crude	
extracts	had	overall	good	yield.	The	distribution	of	 the	material	between	 the	 fractions	
for	each	crude	extract	is	represented	in	figure	11.	
	
The	 amounts	 of	material	 in	 the	 six	 different	 fractions	 from	 the	 extracts	 X701A.2	 and	
XY701A.2	were	 very	 similar,	 and	 fractions	 1	 and	 2	 contained	most	 of	 the	material	 in	
both	of	 them	 (Fig.	 11).	 Fraction	1	 contained	50%	of	 the	 total	mass,	wheras	 fraction	2	
contained	30-40%.	Fraction	3,	4,	5	and	6	held	the	rest	of	the	mass,	around	10-20%.		
		




from	 the	 prefractionation.	 Each	 crude	 extract	 were	 prefractionated	 into	 six	 fractions.	 The	 most	 polar	
compounds	 were	 eluted	 in	 fraction	 1	 (blue)	 and	 2	 (red),	 less	 polar	 compounds	 were	 eluted	 in	 fractions	 3	
(green)	and	4	(purple)	and	the	more	non-polar	compounds	were	eluted	in	fraction	5	(turquois)	and	6	(orange).			


























mass	 in	both	X702D.2	and	XY702D.2.	However,	 fraction	2	contained	about	55%	of	 the		
XY702D.2,	but	only	5%	for	X702D.2	whilst	the	fraction	6	is	the	largest.	The	X703C.2	and	






The	 48	 fractions	 from	 the	 eight	 prefractionated	 fermentations	 were	 tested	 for	
antibacterial	 activity.	Only	 activity	 against	S.	agalactiae	was	 found	of	 the	 five	 bacteria	
tested	 against	 (Table	 12).	 Five	 fractions	 were	 active	 or	 questionable	 and	 included	
XY701A.2-5,	 XY705D.2-5,	 X703C.2-5,	 XY703C.2-5	 and	 XY705B.2-5	 (Fig.	 12).	 All	 of	 the	







against	 S.	 agalactiae.	 The	 active	 fractions	 against	 S.	 agalactiae	 were	 the	 following	 XY702D.2-5,	
X703C.2-5	 and	 XY705B.2-5	with	OD600	 under	0.05.	 The	 questionable	 fractions	 against	S.	agalactiae	







Sample	 E.	coli	 S.	agalactiae		 P.	aeruginosa		 S.	aureus		 E.	faecalis		
X701A.2-5	 ÷	 ÷	 ÷	 ÷	 ÷	
XY701A.2-5	 ÷	 +	 ÷	 ÷	 ÷	
X702D.2-5	 ÷	 ÷	 ÷	 ÷	 ÷	
XY702D.2-5	 ÷	 ++	 ÷	 ÷	 ÷	
X703C.2-5	 ÷	 ++	 ÷	 ÷	 ÷	
XY703C.2-5	 ÷	 +	 ÷	 ÷	 ÷	
X705B.2-5	 ÷	 ÷	 ÷	 ÷	 ÷	








on	 S.	 agalactiae	 for	 determining	 the	 lowest	 inhibitory	 concentration.	 The	 highest	
concentration	tested	(50 µg/mL)	was	the	same	as	the	primary	screening.	The	first	retest	
gave	no	inhibition	in	any	of	the	test	concentrations.	The	second	retest	was	conducted	to	
see	 if	 there	was	a	solubility	 issue	with	the	fractions	and	only	 fraction	XY702D.2-5	was	
found	 active	 (Table	 13).	 The	 results	 from	 the	 primary	 antibacterial	 screening	 and	




Concentration		 XY701A.2-5	 XY702D.2-5	 X703C.2-5	 XY703C.2-5	 XY705B.2-5	
50	µg/mL	 ÷	 ++	 ÷	 ÷	 ÷	
25	µg/mL	 ÷	 ÷	 ÷	 ÷	 ÷	
12,5	µg/mL	 ÷	 ÷	 ÷	 ÷	 ÷	







Of	 the	 48	 fractions,	 five	were	 active	 against	 S.	agalactiae	 in	 the	 primary	 antibacterial	






In	 the	 active	 fraction	 XY701A.2-5,	 peaks	 were	 found	 that	 were	 not	 present	 in	 the	
inactive	fraction	X701A.2	from	a	monoculture	fermentation	(Fig.	13).	Peaks	at	m/z	527,	










In	 fraction	 XY703C.3-5	 the	 compounds	 at	m/z	 527,	 553	 and	 555	were	 found,	 but	 not	
compound	m/z	 581	 as	 previously	 described	 in	 XY701A.2-5	 and	 XY702D.2-5	 (Fig.	 15).	
Again,	 as	 for	 the	 other	monocultures	 X701A.2-5	 and	 X702D.2-5,	 none	 of	 these	 peaks	
were	 found	 in	 X703C.2-5.	 The	 fraction	 X703C.2-5	 had	 antibacterial	 activity,	 but	 no	
specific	 peaks	 were	 found	 that	 could	 be	 responsible	 for	 that	 activity.	 The	 fraction	
XY705B.2-5	had	the	same	peaks	as	the	other	co-culture	fractions,	namely	m/z	527,	553,	
555	 and	 581	 (Fig.	 16).	 No	 peaks	with	 corresponding	 retention	 times	 and	m/z	values	
were	found	in	X705B.2-5.		
Figure	14:	Chromatograms	of	 the	MS	analysis	of	XY702D.2-5	(A)	and	X702D.2-5	 (B)	with	ESI+.	
All	 compounds	 are	 sodium	 adducts.	 There	 was	 found	 four	 peaks	 (527,	 553,	 555	 581)	 in	
chromatogram	B,	which	was	not	present	in	chromatogram	A.	






the	 sodium	 adduct	 of	 the	 molecule	 ([M+Na]+)	 and	 the	 elemental	 composition	 was	
calculated	 to	 be	C26H48O9.	 Peak	553	had	 a	m/z	553.3348	 and	 a	 retention	 time	of	 9.79	




m/z	581.3671	 and	 a	 retention	 time	 of	 10.48	 min.	 The	 mass	 represented	 the	 sodium	

















Peak	 Retention	time	 m/z	[M+Na+]	 Elemental	composition		
527	 9.01	 527.3192	 C26H48O9	
553	 9.79	 553.3348	 C28H50O9	
555	 10.15	 555.3504	 C28H52O9	
581	 10.48	 581.3671	 C30H54O9	
	




The	 fractions	 of	 the	 co-cultivated	 fermentations	 contained	 the	 same	 compounds,	
independent	 of	 isolate	 and	 fermentation	 media	 used.	 The	 only	 common	 parameters	
these	have	are	co-cultivation	with	Leeuwenhoekiella	sp.	After	the	discoveries	in	3.8.1,	the	



























The	 marine	 environment	 provides	 a	 unique	 diversity	 and	 is	 a	 good	 source	 for	
discovering	 novel	 bioactive	 compounds.	 Lately,	 there	 has	 been	 an	 increasing	 interest	
towards	marine	fungi,	which	have	proven	to	be	an	excellent	source	for	novel	bioactive	
molecules	with	 antibacterial	 and	 anticancer	 properties	 (Ebel,	 2012).	 Yet,	 prior	 to	 this	
study,	the	five	marine	fungi	selected	(Acremonium	sp.	TS7,	Typhula	sp.,	A.	encephaloides,	
Pseudogumnoacus	sp.	TS12	and	D.	marina)	have	only	been	investigated	to	a	small	extent.	
The	 three	 wood-	 and	 algae-associated	 obligate	 species	 have	 not	 been	 studied	 for	
bioactivity	 before,	whereas	 there	 are	 some	 studies	 on	 the	 two	 remaining	 species	 (e.g.	
Khamthong	et	al.,	2014).	The	marine	fungi	were	fermented	using	the	OSMAC-approach	
with	 four	 different	 media	 and	 with	 two	 different	 temperatures,	 to	 investigate	 their	
antibacterial	and	anticancer	potential.	Half	of	the	fermentations	were	co-cultivated	with	
the	marine	bacteria	Leeuwenhoekiella	 sp.	The	 total	number	of	 fermentations	was	120.	




The	 120	 crude	 extracts	 varied	 in	 the	 terms	 of	 yields.	 D.	marina	 (705)	 had	 overall	 a	




extracts	was	 incubation	 temperature.	Acremonium	sp.	TS7	 (701),	Typhula	sp.	 (702),	A.	
encephaloides	 (703)	and	D.	marina	(705)	all	had	higher	crude	extracts	yields	 from	the	
fermentations	with	15℃	incubations	 (Fig.	6).	Although	 the	natural	habitats	of	 the	 four	
marine	fungi	are	in	cold	water,	they	seemingly	grow	better	at	higher	temperatures.	It	is	
therefore	 possible	 that	 using	 incubations	 at	 higher	 temperature	would	 lead	 to	 better	
growth		(e.g.	20℃	or	30℃).	Contrary	to	the	fermentations	with	15℃	incubation,	the	10℃	
incubation	 also	 had	 100	 rpm	 shaking.	 It	 was	 observed	 that	 the	 mycelia	 in	 the	 15℃	





to	 extract	 an	 explanation,	 besides	 the	 temperature,	 for	 the	 higher	 yield	 overall	 in	 the	
15℃	incubation.	The	other	parameters	selected	 for	 this	study,	 i.e.	 four	different	media	
and	co-cultivation	 (with	Leeuwenhoekiella	 sp.)	did	not	 show	any	effect	on	 the	mass	of	
the	crude	extracts.		
	




sp.	 TS7	 (701)	 was	 isolated	 from	 a	 marine	 sponge	 and	 did	 not	 favor	 any	 of	 the	 four	
media.	Which	media	 type	used	did	not	have	a	 great	 effect	on	extraction	yield	 (Fig.	8).	
The	complex	carbohydrate	media	(SM	and	WM)	had	a	little	higher	crude	extracts	yields	
compared	to	MEM	and	CFM.	The	complex	carbohydrates	media	(SW	and	VM)	were	not	








There	 were	 120	 fermentations	 that	 were	 extracted.	 The	 fermentations	 with	
Pseudogumnoacus	sp.	TS12	(704)	were	contaminated	and	excluded	from	further	work.	
The	 remaining	 96	 crude	 extracts	 remaining	 would	 have	 taken	 up	 to	 four	 months	 to	
prefractionate	 with	 flash	 chromatography.	 This	 had	 been	 a	 too	 laborious	 work	 to	 be	
included	 in	 the	 project,	 and	 for	 this	 reason	 a	 prioritizing	 of	 the	 extracts	 for	
prefractionation	was	done	based	on	their	potential	antibacterial	and	anticancer	activity.	
The	 crude	 extracts	 were	 tested	 with	 50  µg/mL 	and	 100  µg/mL 	concentrations	 for	
antibacterial	 activity.	 None	 of	 the	 crude	 extracts	 showed	 any	 activity	 against	 the	 five	
human	 pathogenic	 bacteria	 used.	 The	 lack	 of	 activity	 was	 surprising.	 The	 cancer	
screening	 showed	 no	 anticancer	 activity	 for	 the	 96	 crude	 extracts	 tested.	 Five	 of	 the	
samples	 did,	 however,	 give	 a	 reduction	 of	 cell	 survival	 (~75%	cell	 survival)	 (Fig.	 10).	
	 46	
The	reductions	in	these	five	crude	extracts	did	not	go	under	the	cut-off	value	(<	50%	cell	
survival),	 therefore	 they	 cannot	 be	 classified	 as	 active.	 The	 cut-off	 value	 is	 set	 for	
guidance	and	 is	mainly	used	 for	 fractions	 tested.	Fractions	are	more	concentrated	and	
would	 contain	 more	 of	 the	 bioactive	 compounds.	 Crude	 extract	 is	 a	 solution	 that	
contains	 every	 extracted	 metabolite	 and	 is	 therefore	 very	 complex	 (Reid	 &	 Sarker,	
2012).	 The	 complexity	 of	 the	 crude	 extracts	may	 be	 one	 reason	why	 all	 tested	 crude	
extracts	 were	 inactive	 in	 the	 antibacterial	 and	 anticancer	 screening.	 Secondary	
metabolites	are	usually	produced	 in	small	quantities	and	 the	other	components	 in	 the	
crude	 extracts	 can	 overshadow	 these	 secondary	metabolites	 (Pham	 et	 al.,	 2015).	 The	










and	 one	 co-culture,	 both	 with	 same	 media	 within	 the	 isolate.	 The	 following	 samples	
were	prefractionated:	Acremonium	sp.	TS7	X701A.2	and	XY701A.2,	Typhula	sp.	X702D.2	





samples	 (Fig.	 11).	 These	 fractions	 contained	 the	most	 polar	 compounds	 in	 the	 crude	
extracts.	Carbohydrates	and	 salts	 are	usually	 the	main	 contributors	 to	 these	 fractions.	
The	 rest	 of	 the	 fractions	 vary	 in	 yield.	 The	 media	 differs	 in	 composition	 and	 can	
contribute	to	the	variations.	The	amount	of	material	 in	each	fraction	does	not	give	any	
information	of	what	the	fractions	contain.	Fraction	6	in	X702D.2	is	unusually	large	(Fig.	
11).	 The	 overall	 yield	 in	 each	 fraction	 was	 very	 small	 (fraction	 2-5	 <10	 mg).	 When	
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comparing	 them	 with	 fraction	 6	 (80	 mg),	 they	 would	 seem	 abnormally	 small.	 The	
X702D.2	 was	 fermented	 on	 SM,	 which	 had	media	 components	 (particles)	 transferred	
during	the	extraction.	A	possible	explanation	for	the	low	yields	in	the	fractions	may	be	




The	prefractionation	of	 the	eight	crude	extracts	gave	 in	 total	48	 fractions.	These	were	
tested	 for	 antibacterial	 activity.	 From	 the	antibacterial	 screening	 three	active	and	 two	
questionable	fractions	were	found	against	S.	agalactiae	(Table	14).	All	four	marine	fungi	
had	 at	 leaset	 one	 active	 fraction.	 No	 activity	 was	 found	 against	 the	 other	 pathogenic	
bacteria.	The	cut-off	value	is	a	predetermined	value	for	guidance.		Four	out	of	five	active	




are	 usually	 polar	 enough	 to	 penetrate	 the	 cell	membrane	without	 precipitating	 in	 an	
aqueous	 environment.	 The	 five	 active	 fractions	 (XY701A.2-5,	 XY702D.2-5,	 X703C.2-5,	
XY703C.2-5	 and	 X705D.2-5)	 were	 retested	 in	 an	 antibacterial	 assay	 to	 find	 minimal	
inhibition	concentration	(MIC).	The	first	round	of	retesting	showed	no	activity	for	any	of	
the	fractions	tested	and	it	was	suspected	that	the	fractions	had	precipitated	in	the	stock	
plate.	 To	 investigate	 a	 possible	 solubility	 issue,	 a	 new	deep	well	 plate	with	 the	 active	
fractions	was	made.	Even	 though	all	 five	 fractions	should	have	given	activity,	only	 the	
second	 retest	 produced	 a	 hit	 with	 fraction	 XY705D.2-5	 at	 only	 50 µg/mL.	 The	 five	
fractions	 tested	 should	 all	 have	 been	 active	 (or	 questionable)	 at	 50 µg/mL.	 Thus	 it	
appeared	that	the	activities	against	S.	agalactiae	were	lost.	The	absence	of	bioactivity	is	
a	 problem	 and	 the	 solubility	 may	 be	 an	 issue.	 The	 fractions	 were	 dissolved	 in	 2.5%	





The	 48	 fractions	 were	 tested	 for	 anticancer	 activity.	 None	 of	 the	 fractions	 had	 any	
activity	 against	 the	 A2058	 cancer	 cell	 line.	 It	 was	 expected	 to	 find	 more	 activity,	
especially	in	fractions	from	D.	marina	(705)	that	showed	reduction	in	cell	survival	when	
tested	on	crude	extracts.	The	D.	marina	(705)	crude	extracts	that	were	found	to	reduce	
cell	 survival	 were	 not	 the	 same	 crude	 extracts	 that	 were	 prefractionated.	 They	 were	
either	fermented	on	different	media	or	 incubated	at	different	temperatures.	The	crude	
extracts	 that	 reduced	 cell	 survival	 should	 be	 prefractionated	 and	 screened	 for	
anticancer	 activity	 to	 be	 certain	 that	D.	marina	 (705)	 did	 not	 produce	 any	 anticancer	
active	compounds.		
4.5	Dereplication		
The	 following	 samples	 were	 dereplicated:	 Acremonium	 sp.	 TS7	 X701A.2-5	 and	
XY701A.2-5,	 Typhula	 sp.	 X702D.2-5	 and	 XY702D.2-5,	 A.	 encephaloides	 X703C.2-5	 and	
XY703C.2-5,	D.	marina	 X705B.2-5	 and	 XY705B.2-5.	 The	 chromatograms	 revealed	 that	
the	active	 fractions,	 excluding	X703C.2-5,	had	 the	 same	compounds	 that	were	missing	




cultivation	 with	 Leeuwenhoekiella	 sp.	 The	 chromatograms	 of	 the	 active	 and	 inactive	
fractions	indicate	that	the	fungi	are	not	responsible	for	the	antibacterial	activity	found,	
but	 Leeuwenhoekiella	 sp.	 may	 be	 the	 responsible	 species.	 The	 chromatograms	 of	 the	
media	 controls	 with	 Leeuwenhoekiella	 sp.	 added,	 revealed	 three	 out	 of	 the	 four	
compounds	found	in	the	active	fractions.	Only	compound	m/z	581	is	absent	in	the	media	
controls,	 the	 reason	 for	 this	 is	 unknown.	 The	 most	 likely	 explanation	 for	 the	
antibacterial	 activity	 found	 is	 that	Leeuwenhoekiella	 sp.	 is	 the	 responsible	producer	of	




From	 the	 m/z,	 the	 retention	 time	 and	 the	
fragment	 patterns,	 it	 was	 quite	 clear	 at	
Marbio	that	these	compounds	have	been	seen	
before	 and	 that	 the	 compounds	 C26H48O9,	
C28H50O9,	 C28H52O9	 and	 C30H54O9	 are	 most	
likely	 Rhamnolipids.	 These	 four	 compounds,	
with	the	same	molecular	weight	and	formula,	
are	 among	 known	 mono-rhamno-di-lipidic	
congeners	 (Abdel-Mawgoud	 et	 al.,	 2010).	
Rhamnolipids	 are	 a	 diverse	 group	 of	
glycolipids	 that	 have	 been	 extensively	
investigated.	 Rhamnolipids	 typically	 contain	
3-hydroxyfatty	acids	linked	through	a	beta-glycosidic	bond	to	a	mono-	or	di-rhamnoses	
(Vatsa,	 Sanchez,	 Clement,	 Baillieul,	 &	 Dorey,	 2010).	 Rhamnolipids	 are	 produced	 by	
bacteria	 were	 P.	 aeruginosa	 being	 the	 most	 known	 producer,	 but	 several	 other	
rhamnolipid-producing	bacteria	have	been	reported.	The	functions	of	rhamnolipids	are	
unclear	 (Abdel-Mawgoud	 et	 al.,	 2010).	 Most	 rhamnolipids	 have	 been	 reported	 as	
powerful	 biosurfactants	 and	 antimicrobial	 properties	 of	 rhamnolipids	 were	 found	 as	
early	 as	 1971	 (Itoh,	 Honda,	 Tomita,	 &	 Suzuki,	 1971).	 They	 have	 shown	 antibacterial	
activity	 against	 both	 gram-positive	 and	 gram-negative	 bacteria	 (Lang	 et	 al	 1989).	
Antifungal	activities	have	also	been	found	(Benincasa,	Abalos,	Oliveira,	&	Manresa,	2004;	
Haba	 et	 al.,	 2003).	 Benincasa	 et	 al.	 (2004)	 found	 a	 varying	 activity	 against	 E.	 coli,	 S.	
aureus,	 P.	 aeruginosa	 and	 S.	 faecalis,	 but	 no	 activity	 was	 found	 against	 these	 bacteria	
strains	in	2.9.2.	Not	necessary	unexpected,	since	the	rhamnolipids	used	by	Benincasa	et	
al.	(2004)	were	far	more	pure	than	fractions	used	on	the	antibacteria	screening	(2.9.2).	
Even	 though	 the	 fractions	 were	 separated	 by	 polarity,	 the	 mixture	 still	 contained	 a	
mixture	of	compounds.	All	of	the	bacteria	controls	with	Leeuwenhoekiella	sp.	contained	
rhamnolipids,	which	indicates	that	these	compounds	may	be	produced	independently	of	









The	 OSMAC-approach	 does	 have	 documented	 effects	 on	 the	 production	 of	 bioactive	
secondary	metabolites,	 either	 as	 inducing	or	 increasing	production	 (Bode	et	 al.,	 2002;	
Schroeckh	et	al.,	2009).	Despite	of	 this,	 the	bioactivity	 found	 in	 the	120	crude	extracts	
and	 48	 fractions	 was	 far	 less	 than	 expected.	 The	 antibacterial	 retest	 did	 not	 give	
consistent	 results,	 as	 four	 out	 of	 five	 fractions	 had	 lost	 the	 activity.	 The	 fermentation	
parameters	selected	did	not	affect	the	production	of	bioactive	compounds	as	expected.	
The	media	that	were	used	contained	either	small	amounts	of	complex	carbohydrates	or	
simple	 carbohydrates.	 This	 makes	 them	 nutrient-poor,	 which	 is	 what	 marine	 fungi	
generally	 prefer.	 One	 of	 the	 purposes	 of	 using	 the	 OSMAC-approach	 is	 to	 stress	 the	
marine	fungi.	The	nutrient-poor	media	may	have	not	stressed	the	marine	fungi	enough	
and	perhaps	a	media	containing	more	nutrients	would	be	more	stressful	for	the	marine	
fungi,	 than	 lowering	 the	 nutrients	 even	 more.	 The	 OSMAC-approach	 is	 a	 try-and-fail	
method;	not	every	altered	parameter	 is	going	to	give	good	results.	Warmer	incubation	
gave	higher	crude	extract	yield.	Starting	new	cultures	may	not	guarantee	that	the	same	
compounds	 are	 produced,	 but	 using	 simple	 modifications	 such	 as	 temperature	
alterations	 can	 beneficial	 in	 discovering	 novel	 compounds.	 Modifications	 of	





in	 the	 60	 fermentations	 that	were	 co-cultivated	with	 Leeuwenhoekiella	 sp.	 The	major	
problems	of	co-cultivations	are	that	bacteria	can	produce	bioactive	molecules	and	take	
over	 the	 culture,	 especially	when	 cultured	with	 generally	 slow-growing	marine	 fungi.	
The	 inoculations	with	Leeuwenhoekiella	 sp.	were	executed	 for	 all	 fermentations	at	 the	
same	day	and	many	of	 the	 fermentations	were	extracted	between	4-8	weeks	after	 the	
inoculation.	There	is	a	great	possibility	that	Leeuwenhoekiella	sp.	overtook	several	of	the	
fermentations	during	incubation.	The	timing	of	 inoculation	may	be	very	crucial	 for	the	
ability	 of	 the	marine	 fungi	 to	 respond	with	 production	 of	 secondary	metabolites	 that	
inhibit	bacteriocidal	or	bacteriostatic	effect.	Too	 long	 incubation	time	and	the	bacteria	
may	 overtake	 the	 culture.	 Too	 short	 and	 the	 fungi	may	not	 be	 able	 to	 respond	 to	 the	
invasion	of	bacteria	and	produce	antibacterial	compounds.	The	dereplication	of	the	five	
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active	 fractions	 identified	 that	 Leeuwenhoekiella	 sp.	 are	 the	 likely	 producer	 of	 the	
bioactive	rhamnolipids.	There	will	always	be	a	probability	that	the	 inoculated	bacteria	




be	 an	 alternative	 to	 the	 more	 traditional	 co-cultivation	 strategy,	 but	 will	 need	 more	










that	 much	 more	 work	 to	 extract	 both	 extracellular	 and	 intracellular	 secondary	

















marine	 bacteria	 Leeuwenhoekiella	 sp.	 In	 total,	 96	 fermentations	 were	 made	 and	
extracted	with	Diaon®	HP-20	 and	methanol.	 The	only	parameter	 that	 increased	 crude	
extracts	yields	was	15℃	incubation.	No	antibacterial	or	anticancer	activity	was	found	in	
the	96	crude	extracts	tested.	Eight	crude	extracts	were	prefractionated	based	on	crude	
extracts	yields,	while	 five	of	48	 fractions	were	 found	active	against	S.	agalactiae.	Mass	
spectrometric	 analysis	 of	 the	 five	 active	 fractions	 and	 bacteria	 controls	 revealed	 the	
same	 compounds	 responsible	 for	 the	 antibacterial	 activity.	 These	 compounds	 were	
identified	as	Rhamnolipids	and	have	known	bioactivity.	The	producer	of	Rhamnolipids	




to:	 not	 enough	 stress;	 wrong	 microorganism	 used	 in	 co-cultivation;	 the	 four	 marine	
fungi	cannot	produce	antibacterial	and	anticancer	secondary	metabolites,	though	this	is	
unlikely.	 The	 potential	 of	 the	 four	 marine	 fungi	 Acremonium	 sp.	 TS7,	 Typhula	 sp.,	 A.	
encephaloides	 and	D.	marina	have	 not	 been	 fully	 explored	 with	 the	 parameters	 used.	
More	 stressful	 growth	 conditions	 should	be	 tested	 in	 the	 future	 or	 a	 genome	analysis	
that	 could	 find	 hidden	 gene	 clusters	 should	 be	 explored.	 Alternative	 extractions	
methods	 could	 also	 be	 explored.	 This	 study	 alone	 cannot	 exclude	 the	 possibility	 that	
Acremonium	 sp.	 TS7,	 Typhula	 sp.,	 A.	 encephaloides	 and	 D.	 marina	 can	 produce	
































































































































































Exploring the Antibacterial and 
Anticancer Potential of Five Marine Fungi
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Marbio, The Norwegian College of Fishery Science, Faculty of Biosciences, Fisheries and 
Economics, UiT – The Arctic University of Norway, Norway
AIMS OF THE STUDY
The marine environment has in little degree been exploited for natural 
products compared to the terrestrial parts of the world. Even less 
research has been done on marine microorganisms. The marine 
environment offers a huge diversity that has through evolution given 
highly adapted and specialized organisms. The traditional methods of 
fermentation using media for optimal growth can restrict the activation 
of metabolic pathways and as a result various metabolites will not be 
formed. The OSMAC-approach (One Strain, Many Compounds) include 
stressing the organism by multiple factors like temperature, competition 
from other species and limitation of nutrients. The theory with the 
OSMAC-approach is that this stress will activate more metabolic 
pathways, resulting in a higher diversity in the secondary metabolites 
produced. 
• Study whether fungal isolates produce different secondary metabolites 
under different fermentation conditions. 
• Identify crude extracts and Flash fractions with anticancer or 
antibacterial activity. 
• Study whether co-cultivation increases production of secondary 
metabolites.
Table 1. Media used 
Four marine fungi isolated from different habitats where studied for 
anticancer and antibacterial activity. Amylocarpus encephaloides and 
Digitatispora marina were both isolated from driftwood in arctic waters. 
Typhula sp. was isolated from seaweeds in Northern Norway. The last 
studied marine fungus was Acremonium sp. that was isolated from a 
deep-sea marine sponge. Four different media were prepared using 
artificial seawater and minimal medium (Table 1, fig. 2). The marine 
bacteria Leeuwenhoekiella sp.(strain M09W024) was used for co-
cultivation. Media controls with and without co-cultivation for each 
media where made. The marine fungi where extracted using the resin 
Diaon® HP-20 as an absorbent. The resin was added two days before 
extraction. The small compounds absorbed by the resin where eluted 
with 100% methanol and vacuum filtration. 
Figure 1. Digitatispora marina (A), Amylocarpus encephaloides (B) and Typhula sp. on agar before 
fermentation.
RESULTS
• Use Flash Chromatography to prefractionate all 96 crude extracts by 
polarity.
• Test fractions for anticancer and antibacterial activity. 
• Dereplicate active fractions. 
FUTURE WORK
A B C
• All species grew better on simple than complex carbohydrates sources, 
although three of the fungi studied were either seaweed- or driftwood-
associated. This indicates that specialized growth media may not be as 
beneficial for growth as expected. 
• The lack of antibacterial activity in the crude extracts was unexpected 
and the concentrations may be too low to be detected in bioassays. 
Furthermore, active compounds may be masked by media components 
and other compounds in the crude extracts. 
• Co-cultivation induced antibacterial activity which suggests co-
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Preliminary results show a trend in the following:
• Simple carbohydrate sources and higher temperature resulted in 
higher biomass production.
• Anticancer activity against human melanoma cell line A2058 was 
observed. The majority of active crude extracts came from low 
temperature with shaking. 
• No antibacterial activity was observed on any of the crude extracts.
• Antibacterial activity was observed in all prefractionated extracts. 
Three out of four of the isolates had only activity in the co-cultivations. 
Figure 2. Illustrates setup for fermentation per isolate 
per media. MO-C = Monoculture, CO-C = Co-
cultivation, MC = Media Control and MC + CO-C = 
Media control + Co-Cultivation. 
MO-C
MO-C
